UnknownNot Applicable

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

United States300 participantsStarted 2023-05-30

Plain-language summary

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Prescribed and taking an antipsychotic medication for 90-days or longer.
✓. Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
✓. Signed an informed consent.
✓. Speaks English fluently.

✕. Suffered a moderate or severe head injury in the last year;
✕. History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
✕. Severe visual impairment that is cannot be corrected by glasses or contacts.

AIMS Score

Timeframe: Baseline

NCT IDNCT06011408

SponsoriRxReminder

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-11-30

Anthony Sterns, Ph.D.